Abstract
The intrinsic fluorescence of synthetic or natural porphyrins is regarded as an attractive characteristic exploited for assisting early cancer diagnosis and/or tumor localization. Single tumor cells circulating in the blood stream can be considered a major step in depicting dissemination of primary tumors, an event of clinical relevance for prognosis, staging or therapy monitoring of cancer. The third leading cause of cancer death in men is colorectal cancer and the hematogenous spreading of primary tumor cells is one of the main events in metastasis of this type of cancer. Hidden in the myriad of circulating blood cells, tumor cells need both a sensitive and affordable detection technique. 5- (3-methoxy)-4-methoxycarbonylphenyl)-10, 15, 20-tris-(4- methoxycarbonylphenyl) - 21, 23-H porphyne is a synthetic porphyrin with a noticeable preference of accumulation in peripheral blood mononuclear cells isolated from cancer patients as assessed by flow cytometry analysis. In addition, we found distinct accumulation of porphyrin depending on cancer type (cutaneous melanoma versus colorectal cancer). These data lead to the possibility of identifying circulating cells based on preferential accumulation of this new porphyrin in circulating tumor cells because, even accumulated in low percentage of cells the registered intensity of fluorescence was high. Selecting the genetic markers for circulating tumor cells is an option, but high costs and high level of know-how can be somewhat a hurdle for a rapid evaluation. Thus our approach with a new porphyrin can be developed in an accurate and innovative fast tracking method for circulating cancer cells, at least in colorectal cancer patients.
Keywords: Colorectal cancer, cutaneous melanoma, peripheral blood mononuclear cells, synthetic porphyrin.
Graphical Abstract
Medicinal Chemistry
Title:Fluorescent Porphyrin with an Increased Uptake in Peripheral Blood Cell Subpopulations from Colon Cancer Patients
Volume: 11 Issue: 4
Author(s): Carolina Constantin and Monica Neagu
Affiliation:
Keywords: Colorectal cancer, cutaneous melanoma, peripheral blood mononuclear cells, synthetic porphyrin.
Abstract: The intrinsic fluorescence of synthetic or natural porphyrins is regarded as an attractive characteristic exploited for assisting early cancer diagnosis and/or tumor localization. Single tumor cells circulating in the blood stream can be considered a major step in depicting dissemination of primary tumors, an event of clinical relevance for prognosis, staging or therapy monitoring of cancer. The third leading cause of cancer death in men is colorectal cancer and the hematogenous spreading of primary tumor cells is one of the main events in metastasis of this type of cancer. Hidden in the myriad of circulating blood cells, tumor cells need both a sensitive and affordable detection technique. 5- (3-methoxy)-4-methoxycarbonylphenyl)-10, 15, 20-tris-(4- methoxycarbonylphenyl) - 21, 23-H porphyne is a synthetic porphyrin with a noticeable preference of accumulation in peripheral blood mononuclear cells isolated from cancer patients as assessed by flow cytometry analysis. In addition, we found distinct accumulation of porphyrin depending on cancer type (cutaneous melanoma versus colorectal cancer). These data lead to the possibility of identifying circulating cells based on preferential accumulation of this new porphyrin in circulating tumor cells because, even accumulated in low percentage of cells the registered intensity of fluorescence was high. Selecting the genetic markers for circulating tumor cells is an option, but high costs and high level of know-how can be somewhat a hurdle for a rapid evaluation. Thus our approach with a new porphyrin can be developed in an accurate and innovative fast tracking method for circulating cancer cells, at least in colorectal cancer patients.
Export Options
About this article
Cite this article as:
Constantin Carolina and Neagu Monica, Fluorescent Porphyrin with an Increased Uptake in Peripheral Blood Cell Subpopulations from Colon Cancer Patients, Medicinal Chemistry 2015; 11 (4) . https://dx.doi.org/10.2174/1573406411666141209095837
DOI https://dx.doi.org/10.2174/1573406411666141209095837 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Imaging Gene-Directed Enzyme Prodrug Therapy
Current Pharmaceutical Biotechnology Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Ambidextrous Cyclooxygenase: An Enduring Target
Inflammation & Allergy - Drug Targets (Discontinued) CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Current Pharmaceutical Design Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Current Molecular Medicine OX40 and OX40L Interaction in Cancer
Current Medicinal Chemistry Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism Current Status of Clinical Trials for Glioblastoma
Reviews on Recent Clinical Trials Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies
Current Topics in Medicinal Chemistry Curcumin Nanomedicine: A Road to Cancer Therapeutics
Current Pharmaceutical Design Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology 6-Bromo-2,3-Dioxoindolin Phenylacetamide Derivatives: Synthesis, Potent CDC25B, PTP1B Inhibitors and Anticancer Activity
Letters in Drug Design & Discovery Radiolabeling Methods and Nuclear Imaging Techniques in the Design of New Polymeric Carriers for Cancer Therapy
Current Applied Polymer Science Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes
Current Genomics Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
Current Cancer Drug Targets Lactoferrin Derived Peptides: Mechanisms of Action and their Perspectives as Antimicrobial and Antitumoral Agents
Mini-Reviews in Medicinal Chemistry